Cytoprotective Roles of a Novel Compound, MHY-1684, against Hyperglycemia-Induced Oxidative Stress and Mitochondrial Dysfunction in Human Cardiac Progenitor Cells

Oxidative Medicine and Cellular Longevity
Woong Bi JangSang-Mo Kwon

Abstract

Diabetic cardiomyopathy (DCM) is tightly linked to heart disorders and dysfunction or death of the cardiomyocytes including resident cardiac progenitor cells (CPCs) in diabetic patients. In order to restore loss of function of resident or transplanted CPCs, much research has focused on novel therapeutic strategies including the discovery of novel function-modulating factors such as reactive oxygen species (ROS) scavengers. Here, we developed and defined a novel antioxidant, MHY-1684, for enhancing the angiogenic potential of CPCs against ROS-related DCM. Short-term treatment with MHY-1684 restored ROS-induced CPC cell death. Importantly, MHY-1684 decreased hyperglycemia-induced mitochondrial ROS generation and attenuated hyperglycemia-induced mitochondrial fragmentation. We observed that the activation process of both Drp1 (phosphorylation at the site of Ser616) and Fis-1 is drastically attenuated when exposed to high concentrations of D-glucose with MHY-1684. Interestingly, phosphorylation of Drp1 at the site of Ser637, which is an inhibitory signal for mitochondrial fusion, is restored by MHY-1684 treatment, suggesting that this antioxidant may affect the activation and inhibition of mitochondrial dynamics-related signaling a...Continue Reading

References

Oct 23, 2001·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·A J GomesA C Tedesco
Jul 12, 2002·Phytotherapy Research : PTR·Hye Rhi ChoiHae Young Chung
Nov 12, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Hiroshi AzumiMitsuhiro Yokoyama
Dec 28, 2006·Hypertension·Eiki Takimoto, David A Kass
Jul 1, 2009·Diabetes Care·Abbas E KitabchiJoseph N Fisher
Nov 5, 2011·Circulation Research·Yun ChenGerald W Dorn
Aug 21, 2012·Circulation Research·Kyriakos N PapanicolaouKenneth Walsh
Mar 2, 2013·Current Pharmaceutical Design·Teresa Vanessa FiorentinoFranco Folli
May 16, 2013·Frontiers in Physiology·Jerome PiquereauFrederic Joubert
Dec 7, 2013·The New England Journal of Medicine·Stephen L Archer
Jun 3, 2014·Biochimica Et Biophysica Acta·Satoru Kobayashi, Qiangrong Liang
Dec 17, 2014·International Journal of Cardiology·Sung Hyun ChoiSang Mo Kwon
Jan 1, 2016·Cell Death & Disease·Y Poloz, V Stambolic
Aug 7, 2017·International Journal of Cardiology·Dimitry A ChistiakovYuri V Bobryshev

❮ Previous
Next ❯

Citations

Jan 8, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Lichan TaoFei Hua
Aug 31, 2019·Oxidative Medicine and Cellular Longevity·Pakhawadee PalungwachiraThamthiwat Nararatwanchai

❮ Previous
Next ❯

Methods Mentioned

BETA
fluorescence-activated cell sorting
FACS
flow cytometry

Software Mentioned

ImageJ

Related Concepts

Related Feeds

Autophagy & Aging: Inhibitors

The feed focuses on the role of nuclear export inhibitors and their effect on autophagy and the aging process.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Cardiac Regeneration

Cardiac regeneration enables the repair of irreversibly damaged heart tissue using cutting-edge science, including stem cell and cell-free therapy. Discover the latest research on cardiac regeneration here.